Activist 13D/13G Filings - Athyrium Opportunities III Acquisition 2 LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-04-18
4:15 pm
Sale
13GAmryt Pharma plc
AMYT
Athyrium Opportunities III Acquisition 2 LP0
0.000%
-44,286,346decrease
(Position Closed)
View
2023-02-14
4:19 pm
Sale
13GCAREMAX INC
CMAX
Athyrium Opportunities III Acquisition 2 LP4,181,075
3.800%
-306,144decrease
(-6.82%)
View
2022-02-11
4:34 pm
Purchase
13GCAREMAX INC
CMAX
Athyrium Opportunities III Acquisition 2 LP4,487,219
5.200%
4,487,219increase
(New Position)
View
2021-02-12
08:01 am
Purchase
13GAmryt Pharma plc
AMYT
Athyrium Opportunities III Acquisition 2 LP44,286,346
24.800%
44,286,346increase
(New Position)
View